Sunday, October 1, 2023
News Media Empire
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
News Media Empire
No Result
View All Result
Home Health

Hong Kong panel advises 1 dose of BioNTech COVID-19 vaccine for teens due to side effect – National | Globalnews.ca

September 16, 2021
in Health
0
Hong Kong panel advises 1 dose of BioNTech COVID-19 vaccine for teens due to side effect - National | Globalnews.ca
0
SHARES
Share on FacebookShare on TwitterShare on RedditShare on Whatsapp


A panel of health experts advising the Hong Kong government has recommended children aged 12-17 should get only one dose of BioNTech’s COVID-19 vaccine after reports of heart inflammation side effects.

Professor Lau Yu-lung, who chairs a health committee advising the government on its vaccination programme, told public broadcaster RTHK the side effect was more prevalent than originally thought.

Get Free Advertise Coin

He said experts therefore decided it was better for teenagers to get only one dose to “greatly reduce the chance of heart inflammation.”

The city’s Department of Health did not provide data on how many cases of heart inflammation side effects have been reported.

Read more:
3rd dose of established COVID-19 vaccine best way to fight Delta variant: BioNTech

But RTHK said that more than 30 teenagers suffered inflammation of the heart since the government started administering the shot to those over 12 from June.

Story continues below advertisement

Hong Kong has been using two COVID-19 vaccines including Sinovac’s shot vaccinating adults, but teenagers are eligible to take the BioNTech vaccine only.

More than 50% of those aged 12-17 have been vaccinated but the government has not said how many doses have been administered so far.

Regulators in the United States, the European Union and the World Health Organization have said that mRNA vaccines from BioNTech/Pfizer and by Moderna are associated with rare cases of myocarditis or pericarditis, but that the benefits of the shots outweigh any risks.

Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms. Pericarditis is an inflammation of the lining around the heart.


Click to play video: 'Israel reports drop in Pfizer COVID-19 vaccine’s effectiveness in preventing infection'






0:59
Israel reports drop in Pfizer COVID-19 vaccine’s effectiveness in preventing infection


Israel reports drop in Pfizer COVID-19 vaccine’s effectiveness in preventing infection – Jul 6, 2021

Pfizer has said it  recognised there could be rare reports of myocarditis after vaccinations, but such side effects were extremely rare.

Story continues below advertisement

BioNTech and its Chinese sales agent Shanghai Fosun Pharmaceutical Group did not immediately reply to Reuters’ requests for comment.

The risk of myocarditis was 18.5 per million doses given among people aged 18 to 24 after their second Pfizer dose and 20.2 per million for that age group among Moderna second dose recipients. The risk decreases with age, according to data from the U.S. Centers for Disease Control and Prevention.

Around 65% of Hong Kong’s residents have had their first vaccine dose, but the take up amongst elderly people remain low due to concerns of side effects.

Hong Kong has largely controlled the coronavirus with no locally transmitted cases in many weeks. The Asian financial hub has recorded around 12,100 cases in total and 213 deaths.

(Reporting by Farah Master; Editing by Miyoung Kim and Lincoln Feast)


View link »









Source link

Tags: BioNTechCoronaviruscoronavirus vaccinesCOVIDcovid vaccinecovid vaccine teenscovid-19HealthHeart InflammationHong KongPfizerWorld
Previous Post

Alberta Health Services looking out of province for ICU beds, staff | CBC News

Next Post

XRP Price Prediction: XRP Struggles At $1.1 As The SEC Denies Ripple To Documents In Lawsuit

Related Posts

Want to sleep like Blue Jays pitcher Yusei Kikuchi? Here's what one expert suggests | CBC Radio
Health

Want to sleep like Blue Jays pitcher Yusei Kikuchi? Here’s what one expert suggests | CBC Radio

October 1, 2023
Children once had their spines checked in Canada. These experts want to bring it back | CBC News
Health

Children once had their spines checked in Canada. These experts want to bring it back | CBC News

October 1, 2023
Student violence on teachers is a growing concern. What can be done? - National | Globalnews.ca
Health

Student violence on teachers is a growing concern. What can be done? – National | Globalnews.ca

September 30, 2023
Next Post
Ripple

XRP Price Prediction: XRP Struggles At $1.1 As The SEC Denies Ripple To Documents In Lawsuit

binance coin

Avalanche, Ethereum Price Analysis: September 16, 2021

Eight lessons from the glitz and glamour of New York Fashion Week

Eight lessons from the glitz and glamour of New York Fashion Week

Discussion about this post

AdvertiseCoin ADCO Get Now Free
News Media Empire

Newsmediaempire is an online news source that provides the latest news and other information about everything that you must need to know. It publishes news related to various fields like world, business, sports, politics, tech, health, lifestyle, and other different exclusive stories.

Let's connect!

Categories

  • Business & Economy
  • Crypto
  • Entertainment
  • Health
  • Lifestyle
  • Money
  • Opinion
  • Politics
  • Science & Tech
  • Sports
  • World News

Recent News

  • What Sean Dyche told prospective new Everton owners in first meeting October 1, 2023
  • OPINION | Why investors should expect a 10% equity market decline every 18 months | Business October 1, 2023
  • 'I compared all the butters in supermarkets – one was better than Lurpak' October 1, 2023

Join Our Newsletter!

    • About Us
    • Contact
    • Privacy Policy
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    No Result
    View All Result
    • About Us
    • Contact
    • Home 1
    • Home 2
    • Home 3
    • Privacy Policy
    • Random
    • Sample Page
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    en English
    ar Arabicbg Bulgarianzh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.